Skip to main content

Advertisement

Log in

Female Pelvic Medicine & Reconstructive Surgery (FPMRS) challenges on behalf of the collaborative research in pelvic surgery consortium (CoRPS): managing complicated cases series 2: management of urinary incontinence in a neurogenic patient

  • Clinical Opinion
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Discussion and management of incontinence in a patient with spina bifida by four international experts followed by a literature review.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (Austria)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Snow-Lisy D, Yerkes E, Cheng E. Update on urological management of spina bifida from prenatal diagnosis to adulthood. J Urol. 2015;194(2):288–96.

    Article  PubMed  Google Scholar 

  2. Mitchell L, Adzick N, Melchionne J, Pasquariello P, Sutton L, Whitehead A. Spina bifida. Lancet. 2004;364(9448):1885–95.

    Article  PubMed  Google Scholar 

  3. Veenboer P, Bosch J, van Asbeck F, de Kort L. Upper and lower urinary tract outcomes in adult myelomeningocele patients: a systematic review. PLoS One. 2012;7(10):e48399.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. McDonnell G, McCann J. Why do adults with spina bifida and hydrocephalus die? A clinic-based study. Eur J Pediatr Surg. 2000;10(Suppl 1):31–2.

    Article  PubMed  Google Scholar 

  5. Schurch B, Stöhrer M, Kramer G, Schmid D, Gaul G, Hauri D. Botulinum-a toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? preliminary results. J Urol. 2000;164(3 Pt 1):692–7.

    Article  CAS  PubMed  Google Scholar 

  6. Peyronnet B, Even A, Capon G, de Seze M et al. Intradetrusor injections of botulinum toxin a in adult patients with spinal dysraphism. J Urol 2018.

  7. Ginsberg D, Gousse A, Keppenne V, et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol. 2012;187(6):2131–9.

    Article  CAS  PubMed  Google Scholar 

  8. Cruz F, Herschorn S, Aliotta P, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2011;60(4):742–50.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Doreen E. Chung.

Ethics declarations

Conflict of interest

Dr. Erin Brennand is the principle investigator for a prospective cohort funded by Contura International and RCT by Boston Scientific: ClinicalTrials.gov Identifier: NCT02480231. No other authors have any disclosures or conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chung, D.E., Yurteri-Kaplan, L.A., Asatiani, T. et al. Female Pelvic Medicine & Reconstructive Surgery (FPMRS) challenges on behalf of the collaborative research in pelvic surgery consortium (CoRPS): managing complicated cases series 2: management of urinary incontinence in a neurogenic patient. Int Urogynecol J 30, 193–196 (2019). https://doi.org/10.1007/s00192-018-3806-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-018-3806-0

Keywords

Navigation